ADAM VOGEL to Intellectual Disability
This is a "connection" page, showing publications ADAM VOGEL has written about Intellectual Disability.
Connection Strength
0.272
-
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndrome. Expert Rev Neurother. 2026 Jun; 26(6):597-607.
Score: 0.145
-
Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals. J Med Genet. 2024 May 21; 61(6):578-585.
Score: 0.127